Difference between revisions of "Team:SYSU-MEDICINE"

Line 21: Line 21:
 
             letter-spacing: 0.1em;
 
             letter-spacing: 0.1em;
  
 +
        }
 +
        #HQ_page h1, h2, h3, h4, h5, p{
 +
            font-family:"Helvetica-Neue-635ac8fbe16985","Arial",sans-serif;
 +
            font-size:inherit;
 
         }
 
         }
 
         /*override wiki*/
 
         /*override wiki*/
Line 38: Line 42:
 
             font-size: 100%;
 
             font-size: 100%;
 
         }
 
         }
−
         .mw-content-ltr ol, .mw-content-rtl .mw-content-ltr ol{
+
         /*.mw-content-ltr ol, .mw-content-rtl .mw-content-ltr ol{*/
−
             margin: 0 0.1;
+
             /*margin: 0 0.1;*/
−
         }
+
         /*}*/
 
         /*nav*/
 
         /*nav*/
 
         .navbar {
 
         .navbar {

Revision as of 10:10, 5 October 2016

MSCavalry

-----MSCs of
next generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of next generation is coming. SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.